Regular Article
Common Variable Immunodeficiency: Clinical and Immunological Features of 248 Patients

https://doi.org/10.1006/clim.1999.4725Get rights and content

Abstract

Common variable immunodeficiency (CVI) is a primary immunodeficiency disease characterized by reduced serum immunoglobulins and heterogeneous clinical features. In these studies we describe the clinical and immunological status of 248 consecutively referred CVI patients of age range 3–79 years who have been followed for a period of 1–25 years. The median age at the time of onset of symptoms was 23 years for males and 28 years for females; the mean age at which the diagnosis of CVI was made was 29 years for males and 33 years for females. Forty percent of patients had impaired T cell proliferation to one or more mitogens; lymphocyte transformation to mitogens was directly related to the level of the serum IgG. Females at all ages had higher levels of serum IgM than males. Survival 20 years after diagnosis of CVI was 64% for males and 67% for females, compared to the expected 92% population survival for males and 94% for females. Parameters associated with mortality in this period were lower levels of serum IgG, poorer T cell responses to phytohemagglutinin, and, particularly, a lower percentage of peripheral B cells (P < 0.006).

References (50)

  • B.C. Guo et al.

    B cell lines from a subset of patients with common variable immunodeficiency undergo enhanced apoptosis associated with an increased display of CD95 (Apo-1/fas), diminished CD38 expression, and decreased IgG and IgA production

    Cell. Immunol.

    (1995)
  • Clin. Exp. Immunol.

    (1997)
  • C. Cunningham-Rundles

    Clinical and immunologic analyses of 103 patients with common variable immunodeficiency

    J. Clin. Immunol.

    (1989)
  • R.A. Hermaszewski et al.

    Primary hypogammaglobulinemia: A survey of clinical manifestations and complications

    Q. J. Med.

    (1993)
  • M.C. Sneller et al.

    New insights into common variable immunodeficiency

    Ann. Int. Med.

    (1993)
  • C.A. Janeway et al.

    Agammaglobulinemia

    Trans. Assoc. Am. Phys.

    (1953)
  • O. Saiki et al.

    Three distinct stages of B-cell defect in common varied immunodeficiency

    Proc. Natl. Acad. Sci. USA

    (1982)
  • S. Cunningham-Rundles et al.

    Defective cellular immune response in vitro in common variable immunodeficiency

    J. Clin. Immunol.

    (1981)
  • M.E. North et al.

    Defective DNA synthesis by T cells in acquired common variable hypogammaglobulinemia on stimulation with mitogens

    Clin. Exp. Immunol.

    (1989)
  • A.J. Stagg et al.

    Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID)

    Clin. Exp. Immunol.

    (1994)
  • I. Kondratenko et al.

    Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells

    Clin. Exp. Immunol.

    (1997)
  • G. Kruger et al.

    Interleukin 2 correction of defective in vitro T cell mitogenesis in patients with common varied immunodeficiency

    J. Clin. Immunol.

    (1984)
  • G. Pastorelli et al.

    Peripheral blood lymphocytes of patients with common variable immunodeficiency produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation with mitogens

    Clin. Exp. Immunol.

    (1989)
  • M.C. Sneller et al.

    Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency

    J. Immunol.

    (1990)
  • Cited by (0)

    View full text